SCHEMBL6953136

SCHEMBL6953136

Cc1nc(OCC=C(F)F)c(C#N)c(N2CCc3ccccc3CC2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.40
KDM4E B2RXH2 7/20 0.40
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
HSD17B10 Q99714 4/20 0.40
HTT P42858 4/20 0.40
HPGD P15428 4/20 0.40
MAPK1 P28482 2/20 0.40
MAPT P10636 6/20 0.38
TP53 P04637 2/20 0.38
CXCR4 P61073 2/20 0.37
POLB P06746 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
RAB9A P51151 1/20 0.34
NPC1 O15118 1/20 0.34
APOBEC3A P31941 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
SQOR Q9Y6N5 1/20 0.33
NPY5R Q15761 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6957783 0.84 HRH4 (0.44) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL6947782 0.83 CXCR4 (0.41) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL6956303 0.83 KDM4E (0.41) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL6951193 0.83 ALDH1A1 (0.41) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL6948352 0.82 ALDH1A1 (0.46) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL6947498 0.81 CXCR4 (0.43) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL6952068 0.80 ALDH1A1 (0.49) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL6945190 0.80 MEN1 (0.38) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL6945186 0.80 MEN1 (0.38) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL6950038 0.78 KDM4E (0.41) ALDH1A1KDM4EMEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed